Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Alternative Dosing Schedules of Azacitidine: A Real-World Study Across South American Centers.
Castelo L, da Silva WF, Lincango M, Buccheri V, Perusini A, Arbelbide J, Iastrebner M, Gonzalez J, Pereyra P, Pereira TDM, Marchi LL, Rocha V, Belli CB, Velloso EDRP. Castelo L, et al. Among authors: arbelbide j. Clin Lymphoma Myeloma Leuk. 2024 Feb 14:S2152-2650(24)00062-4. doi: 10.1016/j.clml.2024.02.003. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38462425 No abstract available.
Severe thrombocytopenia as a predictor of survival and response to hypomethylating agents in myelodysplastic syndromes: A Latin-American cohort of 212 patients.
Lazzarino C, Arbelbide J, Schuster S, Crisp R, González J, Tavares R, Perusini MA, Di Stefano M, Pintos N, Espinosa D, Pimentel M, Rosenhain M, Serrano JC, Enrico A, Iastrebner M, Belli CB. Lazzarino C, et al. Among authors: arbelbide j. Am J Hematol. 2020 Dec;95(12):E323-E326. doi: 10.1002/ajh.25987. Epub 2020 Oct 1. Am J Hematol. 2020. PMID: 32864747 Free article. No abstract available.
Prognostic assessment for chronic myelomonocytic leukemia in the context of the World Health Organization 2016 proposal: a multicenter study of 280 patients.
González JS, Perusini MA, Basquiera AL, Alfonso G, Fantl D, Lima WM, Nucifora E, Lazzarino C, Novoa V, de Andrade Silva MC, Larripa IB, Rocha V, Arbelbide J, Velloso EDRP, Belli CB. González JS, et al. Among authors: arbelbide j. Ann Hematol. 2021 Jun;100(6):1439-1449. doi: 10.1007/s00277-021-04539-3. Epub 2021 May 1. Ann Hematol. 2021. PMID: 33932168
Results with allo-SCT in patients with relapsed/refractory HL treated with anti-PD-1, a multicenter retrospective cohort study: subcommittee of transplantation and cellular therapy (GATMO-TC) of the Argentinian Hematology Society (SAH).
Warley F, Berro M, Palmer S, Castro M, Ferini G, Lopez Orozco M, Otero V, Arbelbide J, Foncuberta C, Yantorno S, Basquiera A. Warley F, et al. Among authors: arbelbide j. Leuk Lymphoma. 2022 Dec;63(14):3508-3510. doi: 10.1080/10428194.2022.2123238. Epub 2022 Sep 16. Leuk Lymphoma. 2022. PMID: 36111702 No abstract available.
37 results